Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 419.90
+6.15 (1.49%)
At close: Oct 16, 2026
Trident Lifeline Market Cap
Trident Lifeline has a market cap or net worth of 5.01 billion as of October 16, 2026. It is the 29,927th most valuable company in the world and the 2,045th biggest in India. Its market cap has increased by 48.03% in one year.
Market Cap
5.01B
Enterprise Value
5.77B
Revenue
1.39B
Global Rank
Country Rank
#2,045 India
PE Ratio
23.45
ChartMarket Cap Chart
Since October 10, 2022, Trident Lifeline's market cap has increased from 1.24B to 5.01B, an increase of 302.90%. That is a compound annual growth rate of 41.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 5.01B | 35.15% |
| Dec 31, 2025 | 3.71B | 15.15% |
| Dec 30, 2024 | 3.22B | 48.94% |
| Dec 29, 2023 | 2.16B | 51.61% |
| Dec 30, 2022 | 1.43B | 14.66% |
| Oct 10, 2022 | 1.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sudarshan Pharma Industries | 9.26B |
| Anuh Pharma | 8.32B |
| Kilitch Drugs (India) | 8.04B |
| ZIM Laboratories | 7.80B |
| Wanbury | 6.74B |
| Albert David | 4.76B |
| Jenburkt Pharmaceuticals | 4.04B |
| Medicamen Biotech | 3.89B |